The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
truist securities expands biotech research team with new analyst appointment
Truist Securities has enhanced its biotech equity research team with the addition of Danielle Brill, who brings extensive experience from her previous roles at Raymond James and other firms. Brill's insights will support the firm's institutional clients in navigating the evolving biotech landscape, alongside a growing team of experts in various sectors. The firm aims to leverage new technologies and high-touch service to deliver differentiated, data-driven content to its clients.
ubs lowers price target for on holding while maintaining buy rating
UBS has lowered its price target for On Holding AG to $65 from $67 while maintaining a Buy rating, reflecting confidence in the company's strong sales growth and margins. Analysts expect at least 26% year-over-year revenue growth for 2025, despite the slight target adjustment. Other firms have also issued positive ratings, highlighting On Holding's brand strength and market positioning, as investors await the upcoming earnings report.
ubs maintains neutral rating on apple ahead of iphone se launch
UBS has maintained a Neutral rating on Apple Inc. with a $236 target, as the anticipated launch of the iPhone SE's fourth generation approaches on February 19. This model will feature an internally designed modem, marking a shift from Qualcomm components. Despite a slight revenue growth of 2.61% over the past year, analysts have expressed concerns about hardware spending and aggressive fiscal estimates, with varying target prices from other firms reflecting differing outlooks on Apple's performance.
ubs raises tempur sealy stock target to seventy eight dollars
UBS has raised its price target for Tempur Sealy International Inc. to $78, maintaining a Buy rating, citing strong stock momentum and strategic initiatives that could enhance earnings. The company is focused on refining retail operations at Mattress Firm and is expected to exceed synergy targets post-acquisition, with analysts projecting significant growth in earnings per share. Recent financial results show a 2% increase in net sales to $1.3 billion and a 14% rise in GAAP EPS to $0.73 in Q3 2024, indicating robust performance.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.